Public Private Partnerships: A Working Model for Open Innovation
How can we widen the real of pre-competitive science? Dr. Johan Weigelt, Chief Scientist of the Structural Genomics Consortium at the Karolinska Institute, joined Pharma IQ to discuss the benefits for R&D restructuring, and how Public Private Partnerships (PPP) are enabling drug discovery.
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.